J&J, AstraZeneca explore if vaccine change could eliminate risk: WSJ

About This Source - CNBC Television

CNBC is an American pay television business news channel, which primarily carries business day coverage of U.S. and international financial markets. Following the end of the business day and on non-trading days, CNBC primarily carries financial and business-themed documentaries and reality shows.

As of February 2015, CNBC is available to approximately 93,623,000 pay television households (80.4% of households with television) in the United States.

Recent from CNBC Television:

  • We don’t have a fire season, we have a fire year, says Cal Fire director
  • Shorter work week makes a happier workforce and that’s a win-win, says journalist
  • MLB’s Cleveland Indians to become the Guardians, starting in 2022
  • CNBC Television published this video item, entitled “J&J, AstraZeneca explore if vaccine change could eliminate risk: WSJ” – below is their description.

    CNBC’s Andrew Ross Sorkin breaks down a Wall Street Journal report about how Johnson & Johnson and AstraZeneca are exploring modifying vaccines.

    CNBC Television YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: AstraZeneca

    AstraZeneca plc/AB (LON: AZN) is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its headquarters in Cambridge, United Kingdom and Södertälje, Sweden. Its R&D is concentrated in Cambridge in United Kingdom, Södertälje in Sweden, and Maryland and Toronto in North America.

    3 Recent Items: AstraZeneca

  • All adults in Sydney urged by ATAGI to ‘strongly consider’ taking AstraZeneca | ABC News
  • GP urges young people to get AstraZeneca | Coronavirus | 9 News Australia
  • NSW COVID-19 update: 136 cases and another death as state announces ‘national emergency’ | ABC News
  • Leave a Comment